First Merchants Corp Abbott Laboratories Transaction History

First Merchants Corp

$1.43 Billion
Q4 2024

A detailed history of First Merchants Corp transactions in Abbott Laboratories stock. As of the latest transaction made, First Merchants Corp holds 56,042 shares of ABT stock, worth $7.4 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

56,042

Previous 58,000 3.38%

Holding current value

$7.4 Million

Previous $6.61 Million 4.14%

% of portfolio

0.44%

Previous 0.46%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$111.93 - $119.39 $219,158 - $233,765	-1,958 Reduced 3.38%	56,042 $6.34 Million
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $101,771 - $120,138	-1,017 Reduced 1.72%	58,000 $6.61 Million
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $1.01 Million - $1.13 Million	-10,069 Reduced 14.57%	59,017 $6.13 Million
Q1 2024 Apr 25, 2024	SELL	$109.52 - $120.96 $373,463 - $412,473	-3,410 Reduced 4.7%	69,086 $7.85 Million
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $862,757 - $1.06 Million	-9,566 Reduced 11.66%	72,496 $7.98 Million
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $360,243 - $432,232	-3,771 Reduced 4.39%	82,062 $7.95 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $287,323 - $320,138	-2,851 Reduced 3.21%	85,833 $9.36 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $90,176 - $106,143	-931 Reduced 1.04%	88,684 $8.98 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $749,072 - $878,777	-7,880 Reduced 8.08%	89,615 $0
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $81,568 - $94,441	843 Added 0.87%	97,495 $9.43 Million
Q2 2022 Jul 26, 2022	BUY	$102.07 - $123.37 $231,086 - $279,309	2,264 Added 2.4%	96,652 $10.5 Million
Q1 2022 Apr 26, 2022	BUY	$114.02 - $139.04 $5,701 - $6,952	50 Added 0.05%	94,388 $11.2 Million
Q4 2021 Jan 27, 2022	BUY	$115.53 - $141.46 $127,083 - $155,606	1,100 Added 1.18%	94,338 $13.3 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $288,850 - $319,552	-2,476 Reduced 2.59%	93,238 $11 Million
Q2 2021 Jul 26, 2021	BUY	$105.79 - $124.53 $109,281 - $128,639	1,033 Added 1.09%	95,714 $11.1 Million
Q1 2021 Apr 22, 2021	SELL	$108.84 - $128.23 $39,835 - $46,932	-366 Reduced 0.39%	94,681 $11.3 Million
Q4 2020 Jan 28, 2021	SELL	$105.0 - $114.42 $9,555 - $10,412	-91 Reduced 0.1%	95,047 $10.4 Million
Q3 2020 Oct 28, 2020	BUY	$91.64 - $111.29 $18,328 - $22,258	200 Added 0.21%	95,138 $10.4 Million
Q2 2020 Jul 23, 2020	BUY	$76.57 - $98.0 $264,702 - $338,786	3,457 Added 3.78%	94,938 $8.68 Million
Q1 2020 Apr 23, 2020	BUY	$62.82 - $91.86 $4,711 - $6,889	75 Added 0.08%	91,481 $7.22 Million
Q4 2019 Jan 30, 2020	BUY	$78.51 - $87.4 $209,935 - $233,707	2,674 Added 3.01%	91,406 $7.94 Million
Q3 2019 Oct 24, 2019	SELL	$81.84 - $88.74 $209,919 - $227,618	-2,565 Reduced 2.81%	88,732 $7.43 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $96,128 - $112,115	1,319 Added 1.47%	91,297 $7.68 Million
Q1 2019 Apr 25, 2019	BUY	$66.22 - $80.06 $98,402 - $118,969	1,486 Added 1.68%	89,978 $7.19 Million
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $524 - $594	-8 Reduced 0.01%	88,492 $6.4 Million
Q3 2018 Oct 24, 2018	BUY	$60.81 - $73.36 $11,493 - $13,865	189 Added 0.21%	88,500 $6.49 Million
Q2 2018 Jul 26, 2018	SELL	$57.57 - $63.54 $53,943 - $59,536	-937 Reduced 1.05%	88,311 $5.39 Million
Q1 2018 Apr 26, 2018	BUY	$56.27 - $63.62 $404,074 - $456,855	7,181 Added 8.75%	89,248 $5.35 Million
Q4 2017 Jan 30, 2018	SELL	$53.68 - $57.47 $134,683 - $144,192	-2,509 Reduced 2.97%	82,067 $3.77 Million
Q3 2017 Oct 31, 2017	BUY	$48.06 - $53.64 $4.06 Million - $4.54 Million	84,576	84,576 $4.51 Million

Others Institutions Holding ABT

# of Institutions

3,238

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.03M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Merchants Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Merchants Corp with notifications on news.

Account

First Merchants Corp Abbott Laboratories Transaction History